Medtronic won European CE Mark approval for a number of its cardiac resynchronization therapy defibrillators (CRT-Ds) to be safe for use under MRI imaging of up to 3 Tesla. The approved devices include the Claria MRI Quad CRT-D SureScan, Amplia MRI Quad CRT-D SureScan, and Compia MRI Quad CRT-D SureScan pacers. Additionally, all previously approved MRI-conditional cardiac implants now have a green light to be used in 3T magnetic resonance scanners in Europe.
All three devices use the firm’s Attain Perfoma MRI SureScan Quadripolar leads that come in three shapes to fit different patients, include steroid on the electrodes, and have short bipolar spacing that helps ameliorate phrenic nerve stimulation
Source: http://
newsroom.medtronic.com
0 comments:
Post a Comment